Plenary 3 - Toxicogenomics session

15:30-17:00 on Thursday 27 March
Session chair(s) including email address(es):

Diana Hendrickx (Maastricht University, NL)                 d.hendrickx@maastrichtuniversity.nl

Rebecca Boyles (NIEHS, NC, USA)                          rebecca.boyles@nih.gov

Note on Location:

SOT ancillary meeting at Sheraton Phoenix Downtown Hotel                       8:30-10:00 MST

http://www.sheratonphoenixdowntown.com/

RDA 3rd plenary, Dublin, Ireland  (remote access)                                        15:30-17:00 GMT

RDA P3 Venue - Suite 689 Conference Phone Dial-In number 00353 1 836 6756

Remote access:

GoToMeeting

1. Please join my meeting.
https://global.gotomeeting.com/meeting/join/164312509

2. Use your microphone and speakers (VoIP) - a headset is recommended. Or, call in using your telephone.

Australia: +61 2 8355 1035+61 2 8355 1035

Austria: +43 (0) 7 2088 2169+43 (0) 7 2088 2169

Belgium: +32 (0) 42 68 0154+32 (0) 42 68 0154

Canada: +1 (647) 497-9373+1 (647) 497-9373

Denmark: +45 (0) 89 88 04 29

Finland: +358 (0) 931 58 4586+358 (0) 931 58 4586

France: +33 (0) 182 880 932+33 (0) 182 880 932

Germany: +49 (0) 811 8899 6930+49 (0) 811 8899 6930

Ireland: +353 (0) 19 036 185+353 (0) 19 036 185

Italy: +39 0 294 75 15 35+39 0 294 75 15 35

Netherlands: +31 (0) 108 080 114+31 (0) 108 080 114

New Zealand: +64 (0) 9 801 0292+64 (0) 9 801 0292

Norway: +47 21 01 89 06+47 21 01 89 06

Spain: +34 911 23 4170+34 911 23 4170

Sweden: +46 (0) 852 500 288+46 (0) 852 500 288

Switzerland: +41 (0) 435 0824 39+41 (0) 435 0824 39

United Kingdom: +44 20 3657 6778+44 20 3657 6778

United States: +1 (213) 493-0014+1 (213) 493-0014

Access Code: 164-312-509
Audio PIN: Shown after joining the meeting

Meeting ID:164-312-509

 
Overview:
The objective of the Toxicogenomics Interoperability Interest Group is to define opportunities toward enhancing interoperability of existing toxicogenomics databases. Toxicogenomics is the application of genomic technology to study the impact that chemical exposures may have on public health. Historically chemical toxicity assessment has relied on time-consuming and costly animal exposure experiments. Toxicogenomics-based cellular models have been proposed and adopted as an alternative to animal testing, resulting in a rapid increase in these data, and associated databases. Meaningfully applying this data to understand the potential chemical effects on human toxicity pathways is a particular challenge facing the public health community. Application of the data requires that the data be accessible and interoperable for scientists to interrogate. Several large databases have been identified during the joint US – European Union “Workshop on Identifying Opportunities for Global Integration of Toxicogenomics Databases” held at the National Institute for Environmental Health Sciences in Durham, North Carolina, USA on June 26 and 27, 2013. During this event there was general agreement among database owners to engage in a collaborative process toward interoperability, which led to the creation of an RDA interest group. To guide the direction of any future database interoperability efforts, user stories and data limitations have been solicited from existing stakeholder groups via an e-questionnaire. The results of this survey were discussed on our first RDA session at RDA 2nd plenary.

This is the second RDA session and a follow up on the first session that has been held at RDA 2nd Plenary in Washington DC, USA.

The session will review the progress of the group since RDA 2nd plenary, discuss new collaborations and our plans to define and implement a use case of toxicogenomics interoperability.

 
Links to additional reading material:

Group web page:

https://www.rd-alliance.org/group/toxicogenomics-interoperability-ig.html

Toxicogenomics Interoperability IG Charter:

https://www.rd-alliance.org/filedepot?cid=132&fid=138

Sheets, poster and summary previous RDA session (RDA 2nd plenary):

https://rd-alliance.org/filedepot/folder/147

 
Agenda
 

Time (Dublin)

Time (Phoenix)

 

15:30

8:30

Welcome

15:35

8:35

Introduction for newcomers in the Toxicogenomics Interoperability IG

15:50

8:50

Summary outcome Breakout session RDA 2nd plenary

16:05

9:05

Summary of progress since RDA 2nd plenary

16:20

9:20

Discussion: Use case + implementation

16:50

9:50

Closing remarks